Clinical trial

A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)

NCT05865002

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-09-05

PhasePHASE1

Study timeline

Study start (actual)2023-09-05Date precision: day

Registry last updated2026-04-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsed Malignant Solid Neoplasmunresolved

Interventions

AUR107DRUG

Sponsors & collaborators

Aurigene Discovery Technologies Limitedlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05865002 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.